Ligand validation:6D62

TRS: 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6D62_TRS_A_204	69%	40%	0.098	0.913	1.25	1.13	-	1	0	0	100%	1
1YFU_TRS_A_400	65%	39%	0.11	0.912	1.08	1.37	-	2	0	0	100%	1
1YFW_TRS_A_400	61%	38%	0.121	0.909	1.09	1.42	1	2	0	0	100%	1
6D61_TRS_A_204	59%	42%	0.104	0.887	1.18	1.1	-	1	0	0	100%	1
1YFX_TRS_A_400	56%	38%	0.16	0.931	1.07	1.41	-	2	0	0	100%	1
5V28_TRS_A_203	48%	59%	0.21	0.955	0.36	1.17	-	1	0	0	100%	1
6R55_TRS_A_301	99%	76%	0.047	0.976	0.3	0.64	-	-	0	0	100%	1
3UG4_TRS_C_485	98%	58%	0.06	0.983	0.66	0.91	-	-	0	0	100%	1
6WGQ_TRS_A_410	98%	88%	0.064	0.984	0.24	0.42	-	-	0	0	100%	1
3UG5_TRS_D_485	98%	66%	0.065	0.984	0.29	0.97	-	-	0	0	100%	1
6R54_TRS_A_301	96%	70%	0.061	0.971	0.38	0.75	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.